The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Obesity, inflammation, and liver cancer
Open accessAbstract
Obesity has become a universal and major public health problem with increasing prevalence in both adults and children in the 21st century, even in developing countries. Extensive epidemiological studies reveal a strong link between obesity and development and progression of various types of cancers. The connection between obesity and liver cancer is particularly strong and obesity often results in liver diseases such as non-alcoholic fatty liver disease (NAFLD) and the more severe non-alcoholic steatohepatitis (NASH). NASH is characterized by fatty liver inflammation and is believed to cause fibrosis and cirrhosis. The latter is a known liver cancer risk factor. In fact due to its much higher prevalence obesity may be a more substantial contributor to overall hepatocellular carcinoma burden than infection with hepatitis viruses. Here we review and discuss recent advances in elucidation of cellular and molecular alterations and signaling pathways associated with obesity and liver inflammation and their contribution to hepatocarcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Self-citationOverweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Self-citationThe hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578 · cited 1×
“Histological studies have revealed the accumulation of p62, a hallmark of autophagy, during steatohepatitis [125, 126].”
BackgroundPrevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002
Hedley, A. A. (2004) · JAMA · doi:10.1001/jama.291.23.2847 · Cited by 4,460
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Ogden, C. L. (2002) · JAMA · doi:10.1001/jama.288.14.1728 · Cited by 4,060
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Haslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 2×
“NF-κB is a collection of protein dimers that control the transcription of a host of target genes [98].”
Self-citationOverweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Self-citationEndoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802
Adipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606 · cited 1×
“Leptin-deficient (ob/ob) or leptin receptor-deficient (db/db) mice spontaneously develop obesity even on normal chow [77–79].”
BackgroundPhosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.1964 · Cited by 2,230
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
Hardie, D. G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2249 · Cited by 2,216
Laplante, M., & Sabatini, D. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.051011 · Cited by 2,170
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,083
IKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Self-citationPark, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764 · cited 10×
“Consumption of HFD led to a marked increase in HCC incidence, multiplicity and size and as observed in humans, the effect was more pronounced in males than in females [8].”
BackgroundMethodInfluentialSelf-citationYamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., et al. (2007) · Nature Medicine · doi:10.1038/nm1557 · Cited by 1,396
Inflammation meets cancer, with NF-κB as the matchmaker
Ben-Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,373
Self-citationAutophagy-deficient mice develop multiple liver tumors
Takamura, A., Komatsu, M., Hara, T., Sakamoto, A., Kishi, C., Waguri, S., Eishi, Y., Hino, O., Tanaka, K., & Mizushima, N. (2011) · Genes & Development · doi:10.1101/gad.2016211 · Cited by 1,342 · cited 1×
“Curiously, disruption of autophagy, as occurs in ATG7 or ATG5 knockout mice, leads to spontaneous HCC development[146, 147].”
BackgroundNonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,336
Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ
Trayhurn, P., & Beattie, J. H. (2001) · Proceedings of the Nutrition Society · doi:10.1079/pns200194 · Cited by 1,259
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,242
The stomach is a source of leptin
Bado, A., Levasseur, S., Attoub, S., Kermorgant, S., Laigneau, J.-P., Bortoluzzi, M.-N., Moizo, L., Lehy, T., Guerre-Millo, M., Le Marchand-Brustel, Y., et al. (1998) · Nature · doi:10.1038/29547 · Cited by 1,221
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Minireview: The Adipocyte—At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis
Rajala, M. W., & Scherer, P. E. (2003) · Endocrinology · doi:10.1210/en.2003-0580 · Cited by 1,190
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Self-citationOBESE, A NEW MUTATION IN THE HOUSE MOUSE*
INGALLS, A. M., DICKIE, M. M., & SNELL, G. D. (1950) · Journal of Heredity · doi:10.1093/oxfordjournals.jhered.a106073 · Cited by 1,090
Leptin: a review of its peripheral actions and interactions
Margetic, S., Gazzola, C., Pegg, G., & Hill, R. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802142 · Cited by 1,005
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Autophagy suppresses tumor progression by limiting chromosomal instability
Mathew, R., Kongara, S., Beaudoin, B., Karp, C. M., Bray, K., Degenhardt, K., Chen, G., Jin, S., & White, E. (2007) · Genes & Development · doi:10.1101/gad.1545107 · Cited by 938
Interleukin-6 induces cellular insulin resistance in hepatocytes.
Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3391 · Cited by 883 · cited 1×
“Insulin sensitivity in leptin-deficient ob/ob mice is improved by IL-6 depletion using a neutralizing antibody [62], moreover, a recent study has shown that IL-6 can inhibit insulin signaling in hepatocytes [63].”
BackgroundLeptin Signaling, Adiposity, and Energy Balance
JÉQUIER, E. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04293.x · Cited by 789
Castell, J. V., Gómez-lechón, M. J., David, M., Fabra, R., Trullenque, R., & Heinrich, P. C. (1990) · Hepatology · doi:10.1002/hep.1840120517 · Cited by 757
Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics
Kitamura, T., Koshino, Y., Shibata, F., Oki, T., Nakajima, H., Nosaka, T., & Kumagai, H. (2003) · Experimental Hematology · doi:10.1016/j.exphem.2003.07.005 · Cited by 737
Hawley, S. A., Gadalla, A. E., Olsen, G. S., & Hardie, D. G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2420 · Cited by 696
Obesity, Hypertension, and the Risk of Kidney Cancer in Men
Chow, W.-H., Gridley, G., Fraumeni, J. F., & Järvholm, B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431804 · Cited by 668
Obesity in anaesthesia and intensive care
Adams, J. P., & Murphy, P. G. (2000) · British Journal of Anaesthesia · doi:10.1093/bja/85.1.91 · Cited by 649
Greten, F. R., Arkan, M. C., Bollrath, J., Hsu, L.-C., Goode, J., Miething, C., Göktuna, S. I., Neuenhahn, M., Fierer, J., Paxian, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.009 · Cited by 616
Self-citationDying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality
Remijsen, Q., Kuijpers, T. W., Wirawan, E., Lippens, S., Vandenabeele, P., & Vanden Berghe, T. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.1 · Cited by 607
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J. Y., Ko, H. J., Barrett, T., Kim, J. K., & Davis, R. J. (2008) · Science · doi:10.1126/science.1160794 · Cited by 604
Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
Inami, Y., Waguri, S., Sakamoto, A., Kouno, T., Nakada, K., Hino, O., Watanabe, S., Ando, J., Iwadate, M., Yamamoto, M., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102031 · Cited by 604
Non-alcoholic fatty liver disease: The mist gradually clears
de Alwis, N. M. W., & Day, C. P. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.009 · Cited by 603
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 597
Chen, C., Yang, H., Yang, W., Liu, C., Chen, P., You, S., Wang, L., Sun, C., Lu, S., Chen, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.073 · Cited by 549
Solinas, G., Vilcu, C., Neels, J. G., Bandyopadhyay, G. K., Luo, J.-L., Naugler, W., Grivennikov, S., Wynshaw-Boris, A., Scadeng, M., Olefsky, J. M., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.011 · Cited by 513
Self-citationOfei, F., Hurel, S., Newkirk, J., Sopwith, M., & Taylor, R. (1996) · Diabetes · doi:10.2337/diab.45.7.881 · Cited by 510
Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity
Ouchi, N., Higuchi, A., Ohashi, K., Oshima, Y., Gokce, N., Shibata, R., Akasaki, Y., Shimono, A., & Walsh, K. (2010) · Science · doi:10.1126/science.1188280 · Cited by 490
Chronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Klover, P. J., Zimmers, T. A., Koniaris, L. G., & Mooney, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2784 · Cited by 488
Sakurai, T., He, G., Matsuzawa, A., Yu, G.-Y., Maeda, S., Hardiman, G., & Karin, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.016 · Cited by 487
Self-citationLeptin regulation of the immune response and the immunodeficiency of malnutrition 1
Faggioni, R., Feingold, K. R., & Grunfeld, C. (2001) · The FASEB Journal · doi:10.1096/fj.01-0431rev · Cited by 472
Adipokines and cytokines in non‐alcoholic fatty liver disease
JARRAR, M. H., BARANOVA, A., COLLANTES, R., RANARD, B., STEPANOVA, M., BENNETT, C., FANG, Y., ELARINY, H., GOODMAN, Z., CHANDHOKE, V., et al. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03586.x · Cited by 430
He, G., Yu, G.-Y., Temkin, V., Ogata, H., Kuntzen, C., Sakurai, T., Sieghart, W., Peck-Radosavljevic, M., Leffert, H. L., & Karin, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.048 · Cited by 427
Self-citationEnvironmental factors and risk for hepatocellular carcinoma
Yu, M. C., & Yuan, J.-M. (2004) · Gastroenterology · doi:10.1016/j.gastro.2004.09.018 · Cited by 426
Association between adiponectin and mediators of inflammation in obese women
Engeli, S., Feldpausch, M., Gorzelniak, K., Hartwig, F., Heintze, U., Janke, J., Möhlig, M., Pfeiffer, A. F. H., Luft, F. C., & Sharma, A. M. (2003) · Diabetes · doi:10.2337/diabetes.52.4.942 · Cited by 422 · cited 2×
“Hypertrophic adipocytes secrete free fatty acids (FFAs), and together with various immune cells they release various pro-inflammatory cytokines including tumor necrosis factor (TNF), inerleukin-6 (IL-6), IL-1β, IL-8, IL-10, IL-18 and IL-17, as well as more specialized adipokines, such as leptin and adiponectin [8, 34–…”
BackgroundTSC2: filling the GAP in the mTOR signaling pathway
Li, Y. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.11.007 · Cited by 419
Obesity and hepatocellular carcinoma
Caldwell, S. H., Crespo, D. M., Kang, H. S., & Al-Osaimi, A. M. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.021 · Cited by 396
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
Schattenberg, J. M., Singh, R., Wang, Y., Lefkowitch, J. H., Rigoli, R. M., Scherer, P. E., & Czaja, M. J. (2006) · Hepatology · doi:10.1002/hep.20999 · Cited by 384 · cited 1×
“Although several pathways have been implicated in metabolic inflammation, the IKK and JNK signaling pathways in adipocytes, macrophages and hepatocytes have emerged as the pivotal mediators of obesity-induced inflammation and even systemic metabolic disorders [8, 42, 97, 101, 111, 112].”
BackgroundRautou, P.-E., Mansouri, A., Lebrec, D., Durand, F., Valla, D., & Moreau, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.006 · Cited by 383
Lee, M.-S., Hsu, C.-C., Wahlqvist, M. L., Tsai, H.-N., Chang, Y.-H., & Huang, Y.-C. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-20 · Cited by 380
The evolving role of inflammation in obesity and the metabolic syndrome
Lee, Y.-H., & Pratley, R. E. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0071-7 · Cited by 369
Iikuni, N., Kwan Lam, Q., Lu, L., Matarese, G., & Cava, A. (2008) · Current Immunology Reviews · doi:10.2174/157339508784325046 · Cited by 365
p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway
Hui, L., Bakiri, L., Mairhorfer, A., Schweifer, N., Haslinger, C., Kenner, L., Komnenovic, V., Scheuch, H., Beug, H., & Wagner, E. F. (2007) · Nature Genetics · doi:10.1038/ng2033 · Cited by 352
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
Nair, S., Mason, A., Eason, J., Loss, G., & Perrillo, R. P. (2002) · Hepatology · doi:10.1053/jhep.2002.33713 · Cited by 348
JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction
Solinas, G., & Karin, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-151340 · Cited by 347
Self-citationThe Protein Kinase IKKɛ Regulates Energy Balance in Obese Mice
Chiang, S.-H., Bazuine, M., Lumeng, C. N., Geletka, L. M., Mowers, J., White, N. M., Ma, J.-T., Zhou, J., Qi, N., Westcott, D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.06.046 · Cited by 344
Interleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice
Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M., McKenzie, A. N., Xu, D., Sattar, N., McInnes, I. B., & Liew, F. Y. (2010) · Circulation Research · doi:10.1161/circresaha.110.218867 · Cited by 324
Müller, S., Martin, S., Koenig, W., Hanifi-Moghaddam, P., Rathmann, W., Haastert, B., Giani, G., Illig, T., Thorand, B., & Kolb, H. (2002) · Diabetologia · doi:10.1007/s00125-002-0829-2 · Cited by 311
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
Hashimoto, E., Yatsuji, S., Tobari, M., Taniai, M., Torii, N., Tokushige, K., & Shiratori, K. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-008-2262-x · Cited by 308
Donadon, V., Balbi, M., Mas, M. D., Casarin, P., & Zanette, G. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02223.x · Cited by 292
Metformin and cancer: new applications for an old drug
Kourelis, T. V., & Siegel, R. D. (2012) · Medical Oncology · doi:10.1007/s12032-011-9846-7 · Cited by 289
IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα
Maeda, S., Chang, L., Li, Z.-W., Luo, J.-L., Leffert, H., & Karin, M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00301-7 · Cited by 286
Self-citationSolinas, G., Naugler, W., Galimi, F., Lee, M.-S., & Karin, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607626103 · Cited by 284
Self-citationDisruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis
Inokuchi, S., Aoyama, T., Miura, K., Österreicher, C. H., Kodama, Y., Miyai, K., Akira, S., Brenner, D. A., & Seki, E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909781107 · Cited by 279
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.
Patton, J. S., Shepard, H. M., Wilking, H., Lewis, G., Aggarwal, B. B., Eessalu, T. E., Gavin, L. A., & Grunfeld, C. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8313 · Cited by 277
Interleukin-6 depletion selectively improves hepatic insulin action in obesity.
Klover, P. J., Clementi, A. H., & Mooney, R. A. (2005) · Endocrinology · doi:10.1210/en.2004-1468 · Cited by 273
How to Live Long and Prosper: Autophagy, Mitochondria, and Aging
Yen, W.-L., & Klionsky, D. J. (2008) · Physiology · doi:10.1152/physiol.00013.2008 · Cited by 265
Sell, H., Divoux, A., Poitou, C., Basdevant, A., Bouillot, J.-L., Bedossa, P., Tordjman, J., Eckel, J., & Clément, K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2374 · Cited by 262
Effects of Etanercept in Patients With the Metabolic Syndrome
Bernstein, L. E., Berry, J., Kim, S., Canavan, B., & Grinspoon, S. K. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.8.902 · Cited by 257
Wang, Y., Lam, K. S. L., Chan, L., Chan, K. W., Lam, J. B. B., Lam, M. C., Hoo, R. C. L., Mak, W. W. N., Cooper, G. J. S., & Xu, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513907200 · Cited by 256
Childhood Obesity and a Diabetes Epidemic
Rocchini, A. P. (2002) · New England Journal of Medicine · doi:10.1056/nejm200203143461112 · Cited by 255
Regulation of leptin production: sympathetic nervous system interactions
Rayner, D. V., & Trayhurn, P. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100198 · Cited by 250
Obesity and diabetes as a risk factor for hepatocellular carcinoma
Regimbeau, J. M., Colombat, M., Mognol, P., Durand, F., Abdalla, E., Degott, C., Degos, F., Farges, O., & Belghiti, J. (2004) · Liver Transplantation · doi:10.1002/lt.20033 · Cited by 227
Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance†
Singh, R., Wang, Y., Xiang, Y., Tanaka, K. E., Gaarde, W. A., & Czaja, M. J. (2009) · Hepatology · doi:10.1002/hep.22578 · Cited by 223
Is obesity an independent prognosis factor in woman breast cancer?
Majed, B., Moreau, T., Senouci, K., Salmon, R. J., Fourquet, A., & Asselain, B. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9785-3 · Cited by 220
Autophagy in nonalcoholic steatohepatitis
Amir, M., & Czaja, M. J. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.4 · Cited by 216
mTORC1 phosphorylates the ULK1-mAtg13-FIP200 autophagy regulatory complex
Chan, E. Y. (2009) · Science Signaling · doi:10.1126/scisignal.284pe51 · Cited by 214
Selective Autophagy in Cancer Development and Therapy
Dikic, I., Johansen, T., & Kirkin, V. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4027 · Cited by 212
Weyer, C., Yudkin, J. S., Stehouwer, C. D. A., Schalkwijk, C. G., Pratley, R. E., & Tataranni, P. A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00626-8 · Cited by 211
Obesity Is an Independent Prognostic Variable in Colon Cancer Survivors
Sinicrope, F. A., Foster, N. R., Sargent, D. J., O'Connell, M. J., & Rankin, C. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2636 · Cited by 202
Decrease in Serum Adiponectin Level Due to Obesity and Visceral Fat Accumulation in Children
Asayama, K., Hayashibe, H., Dobashi, K., Uchida, N., Nakane, T., Kodera, K., Shirahata, A., & Taniyama, M. (2003) · Obesity Research · doi:10.1038/oby.2003.147 · Cited by 199
Nonalcoholic Steatohepatitis in Obesity: A Reversible Condition
ERIKSSON, S., ERIKSSON, K., & BONDESSON, L. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02733.x · Cited by 198
Abdominal Obesity and Breast Cancer Risk
Schapira, D. V., Kumar, N. B., Lyman, G. H., & Cox, C. E. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-3-182 · Cited by 187
IL-17 in obesity and adipogenesis
Ahmed, M., & Gaffen, S. L. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.005 · Cited by 185
Molecular mapping of the mouse ob mutation
Friedman, J. M., Leibel, R. L., Siegel, D. S., Walsh, J., & Bahary, N. (1991) · Genomics · doi:10.1016/0888-7543(91)90032-a · Cited by 181
Vidal, H., Auboeuf, D., De Vos, P., Staels, B., Riou, J. P., Auwerx, J., & Laville, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118786 · Cited by 181
Regulation of Interleukin 8 Production and Gene Expression in Human Adipose Tissue in Vitro1
Bruun, J. M., Pedersen, S. B., & Richelsen, B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7264 · Cited by 174
mTOR mediated anti-cancer drug discovery
Liu, Q., Thoreen, C., Wang, J., Sabatini, D., & Gray, N. S. (2009) · Drug Discovery Today: Therapeutic Strategies · doi:10.1016/j.ddstr.2009.12.001 · Cited by 174
Non-viral causes of hepatocellular carcinoma
Blonski, W. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i29.3603 · Cited by 174
Adipose tissue inflammation in obesity and metabolic syndrome.
Nishimura, S., Manabe, I., & Nagai, R. (2009) · PubMed · Cited by 172
Adiponectin before and after Weight Loss in Obese Children
Reinehr, T., Roth, C., Menke, T., & Andler, W. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031925 · Cited by 170
Yang, S. Q., Lin, H. Z., Hwang, J., Chacko, V. P., & Diehl, A. M. (2001) · PubMed · Cited by 162
Wueest, S., Rapold, R. A., Schumann, D. M., Rytka, J. M., Schildknecht, A., Nov, O., Chervonsky, A. V., Rudich, A., Schoenle, E. J., Donath, M. Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38388 · Cited by 162
Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene
WEINHOLD, B., & RÜTHER, U. (1997) · Biochemical Journal · doi:10.1042/bj3270425 · Cited by 161
Saxena, N. K., Fu, P. P., Nagalingam, A., Wang, J., Handy, J. A., Cohen, C., Tighiouart, M., Sharma, D., & Anania, F. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.001 · Cited by 159
Keynote review: The adipocyte as a drug discovery target
Nawrocki, A. R., & Scherer, P. E. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03569-5 · Cited by 152
Sakaguchi, S., Takahashi, S., Sasaki, T., Kumagai, T., & Nagata, K. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rv-087 · Cited by 146
Gannagé‐Yared, M., Khalifé, S., Semaan, M., Fares, F., Jambart, S., & Halaby, G. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02175 · Cited by 136
Nov, O., Kohl, A., Lewis, E. C., Bashan, N., Dvir, I., Ben‐Shlomo, S., Fishman, S., Wueest, S., Konrad, D., & Rudich, A. (2010) · Endocrinology · doi:10.1210/en.2010-0340 · Cited by 134
Obesity and Breast Cancer Prognosis: Weight of the Evidence
Sinicrope, F. A., & Dannenberg, A. J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.1752 · Cited by 130
Kawashiri, S., Kawakami, A., Yamasaki, S., Imazato, T., Iwamoto, N., Fujikawa, K., Aramaki, T., Tamai, M., Nakamura, H., Ida, H., et al. (2011) · Rheumatology International · doi:10.1007/s00296-009-1303-y · Cited by 129
Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome
Choi, K. M., Ryu, O., Lee, K., Kim, H., Seo, J. A., Kim, S. G., Kim, N. H., Choi, D. S., & Baik, S. H. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.06.019 · Cited by 129
IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ
Hsu, L.-C., Enzler, T., Seita, J., Timmer, A. M., Lee, C., Lai, T., Yu, G., Lai, L., Temkin, V., Sinzig, U., et al. (2010) · Nature Immunology · doi:10.1038/ni.1976 · Cited by 126
Self-citationWunderlich, F. T., Luedde, T., Singer, S., Schmidt‐Supprian, M., Baumgartl, J., Schirmacher, P., Pasparakis, M., & Brüning, J. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707849104 · Cited by 124
From observation to experimentation: leptin action in the mediobasal hypothalamus
Williams, K. W., Scott, M. M., & Elmquist, J. K. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26788d · Cited by 118
Neither LKB1 Nor AMPK Are the Direct Targets of Metformin
Hardie, D. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.032 · Cited by 113
Kang, H. S., Okamoto, K., Kim, Y.-S., Takeda, Y., Bortner, C. D., Dang, H., Wada, T., Xie, W., Yang, X.-P., Liao, G., et al. (2010) · Diabetes · doi:10.2337/db10-0628 · Cited by 109
Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis
Asano, T., Watanabe, K., Kubota, N., Gunji, T., Omata, M., Kadowaki, T., & Ohnishi, S. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06039.x · Cited by 104
Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance
Röhl, M., Pasparakis, M., Baudler, S., Baumgartl, J., Gautam, D., Huth, M., Lorenzi, R. D., Krone, W., Rajewsky, K., & Brüning, J. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18712 · Cited by 104
Gallistl, S., Sudi, K. M., Aigner, R., & Borkenstein, M. H. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801808 · Cited by 103
Regulation of Interleukin 8 Production and Gene Expression in Human Adipose Tissue in Vitro
Bruun, J. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1267 · Cited by 95
Scarpato, R., Verola, C., Fabiani, B., Bianchi, V., Saggese, G., & Federico, G. (2010) · The FASEB Journal · doi:10.1096/fj.10-168427 · Cited by 93
Effect of weight loss on coronary circulation and adiponectin levels in obese women
Coppola, A., Marfella, R., Coppola, L., Tagliamonte, E., Fontana, D., Liguori, E., Cirillo, T., Cafiero, M., Natale, S., & Astarita, C. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.087 · Cited by 92
Bougoulia, M., Triantos, A., & Koliakos, G. (2006) · HORMONES · doi:10.14310/horm.2002.11190 · Cited by 91
Obesity and inflammation in children
Schwarzenberg, S. J., & Sinaiko, A. R. (2006) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2006.08.002 · Cited by 88
Piguet, A., Semela, D., Keogh, A., Wilkens, L., Stroka, D., Stoupis, C. A., St–Pierre, M. V., & Dufour, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.024 · Cited by 82
Hepatic Complications of Obesity
Diehl, A. M. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2009.12.001 · Cited by 82
Wang, Y., Ausman, L. M., Greenberg, A. S., Russell, R. M., & Wang, X. (2008) · International Journal of Cancer · doi:10.1002/ijc.23995 · Cited by 80
Tarantino, G., Colicchio, P., Conca, P., Finelli, C., Minno, M. N. D. D., Tarantino, M., Capone, D., & Pasanisi, F. (2009) · Journal of Inflammation · doi:10.1186/1476-9255-6-6 · Cited by 80
mTOR inhibitors for hepatocellular cancer: a forward-moving target
Treiber, G. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.9.2.247 · Cited by 78
Nobukuni, T., & Thomas, G. (2004) · Novartis Foundation symposium · doi:10.1002/0470869976.ch9 · Cited by 57
Obesity, Inflammatory Signaling, and Hepatocellular Carcinoma—An Enlarging Link
Toffanin, S., Friedman, S. L., & Llovet, J. M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.018 · Cited by 53
Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk, K., Szcześniak, P., Kumor, A., Jasińska, A., Omulecka, A., Pietruczuk, M., Orszulak–Michalak, D., Sporny, S., & Malecka-Panas, E. I. (2009) · PubMed · Cited by 43
TAK1 represses transcription of the human telomerase reverse transcriptase gene
Fujiki, T., Miura, T., Maura, M., Shiraishi, H., Nishimura, S.-I., IMADA, Y., Uehara, N., Tashiro, K., Shirahata, S., & Katakura, Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210331 · Cited by 42
A rabbit model of pediatric nonalcoholic steatohepatitis: The role of adiponectin
Fu, J., Fang, Y., Liang, L., Wang, C., Hong, F., & Dong, G. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.912 · Cited by 35
Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk, K., Szcześniak, P., Kumor, A., Jasińska, A., Omulecka, A., Pietruczuk, M., Orszulak–Michalak, D., Sporny, S., & Malecka-Panas, E. I. (2009) · PubMed · Cited by 35
Pharmacological characterization of a small molecule inhibitor of c-Jun kinase
Cho, H., Black, S. C., Looper, D., Shi, M., Kelly-Sullivan, D., Timofeevski, S. L., Siegel, K., Yu, X., McDonnell, S. R. P., Chen, P., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90298.2008 · Cited by 24
Obesity and Endometrial Cancer: Challenges for Public Health Action
Richardson, L. C., Thomas, C. C., & Bowman, B. A. (2009) · Women s Health · doi:10.2217/whe.09.62 · Cited by 12
Cited by
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Decoding cell death signals in liver inflammation
Brenner, C., Galluzzi, L., Kepp, O., & Kroemer, G. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.033 · Cited by 1,022
Neutrophil plasticity in the tumor microenvironment
Giese, M. A., Hind, L. E., & Huttenlocher, A. (2019) · Blood · doi:10.1182/blood-2018-11-844548 · Cited by 783
Metadata
- Authors
- Sun, B., & Karin, M.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 56
- Issue
- 3
- Pages
- 704-713
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W1980437893
- Cited by
- 496
- References
- 155
- FWCI
- 18.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.